Guía de Práctica Clínica sobre Trastorno Bipolar - GuíaSalud

261. Schaffer A, Zuker P y Levitt A. Randomized, double-blind pilot trial comparing
lamotrigine versus citalopram for the treatment of bipolar depression. Journal of affective
disorders, 2006; 96 (1-2): 95-99.
262. Geddes JR, Calabrese JR y Goodwin GM. Lamotrigine for treatment of bipolar
depression: independent meta-analysis and meta-regression of individual patient data
from five randomised trials. The British journal of psychiatry : the journal of mental
science, 2009; 194 (1): 4-9.
263. Smith L, Cornelius V, Azorin J, Perugi G, Vieta E, Young A y Bowden C. Valproate for
the treatment of acute bipolar depression: systematic review and meta-analysis. J Affect
Disord, 2010; 122 (1-2): 1-9.
264. van der Loos ML, Mulder PG, Hartong EG, Blom MB, Vergouwen AC, de Keyzer HJ,
Notten PJ, Luteijn ML, Timmermans MA, Vieta E y Nolen WA. Efficacy and safety of
lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, doubleblind,
placebo-controlled trial. J Clin Psychiatry, 2009; 70 (2): 223-231.
265. Altshuler LL, Suppes T, Black DO, Nolen WA, Leverich G, Keck PE, Frye MA, Kupka
R, McElroy SL, Grunze H, Kitchen CM y Post R. Lower switch rate in depressed patients
with bipolar II than bipolar I disorder treated adjunctively with second-generation
antidepressants. The American Journal of Psychiatry, 2006; 163 (2): 313-315.
266. Bocchetta A, Bernardi F, Burrai C, Pedditzi M y Del Zompo M. A double-blind study of
L-sulpiride versus amitriptyline in lithium-maintained bipolar depressives. Acta
psychiatrica Scandinavica, 1993; 88: 434-439.
267. Cohn JB, Collins G, Ashbrook E y Wernicke JF. A comparison of fluoxetine imipramine
and placebo in patients with bipolar depressive disorder. International Clinical
Psychopharmacology, 1989; 4: 313-322.
268. Frye MA, Helleman G, McElroy SL, Altshuler LL, Black DO, Keck PE, Jr., Nolen WA,
Kupka R, Leverich GS, Grunze H, Mintz J, Post RM y Suppes T. Correlates of treatmentemergent
mania associated with antidepressant treatment in bipolar depression. Am J
Psychiatry, 2009; 166 (2): 164-172.
269. Goldberg JF, Perlis RH, Ghaemi SN, Calabrese JR, Bowden CL, Wisniewski S,
Miklowitz DJ, Sachs GS y Thase ME. Adjunctive antidepressant use and symptomatic
recovery among bipolar depressed patients with concomitant manic symptoms: findings
from the STEP-BD. Am J Psychiatry, 2007; 164: 1348-1355.
270. Grossman F, Potter WZ, Brown EA y Maislin G. A double-blind study comparing
idazoxan and bupropion in bipolar depressed patients. Journal of affective disorders,
1999; 56: 237-243.
271. Himmelhoch JM, Thase ME, Mallinger AG y Houck P. Tranylcypromine versus
imipramine in anergic bipolar depression. American Journal of Psychiatry, 1991; 148:
910-916.
272. Leverich GS, Altshuler LL, Frye MA, Suppes T, McElroy SL, Keck PE, Kupka RW,
Denicoff KD, Nolen WA, Grunze H, Martinez MI y Post RM. Risk of switch in mood
polarity to hypomania or mania in patients with bipolar depression during acute and
continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood
stabilizers. The American Journal of Psychiatry, 2006; 163 (2): 232-239.
273. Nemeroff CB, Evans DL, Gyulai L, Sachs GS, Bowden CL, Gergel IP, Oakes R y Pitts C.
Double-blind, placebo-controlled comparison of imipramine and paroxetine in the
treatment of bipolar depression. American Journal of Psychiatry, 2001; 158: 906-912.
274. Sachs GS, Nierenberg AA, Calabrese JR, Marangell LB, Wisniewski SR, Gyulai L,
Friedman ES, Bowden CL, Fossey MD, Ostacher MJ, Ketter TA, Patel J, Hauser P,
Rapport D, Martinez JM, Allen MH, Miklowitz DJ, Otto MW, Dennehy EB y Thase ME.
Effectiveness of adjunctive antidepressant treatment for bipolar depression. The New
England journal of medicine, 2007; 356 (17): 1711-1722.
275. Silverstone T. Moclobemide vs imipramine in bipolar depression: a multicentre doubleblind
clinical trial. Acta psychiatrica Scandinavica, 2001; 104: 104-109.
GUÍA DE PRÁCTICA CLÍNICA SOBRE TRASTORNO BIPOLAR 415